VF
EYEGW

Virtu Financial’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History

Virtu Financial’s Portfolio EYEGW Stock Details EYEGW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,391
Closed -$2K – 2910
2017
Q4 		$2K Sell
12,391
-8,190
-40% -$753 ﹤0.01% 2295
2017
Q3 		$2K Buy
+20,581
New +$2.1K ﹤0.01% 2458

Other funds holding EYEGW

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Virtu Financial's EYEGW Position: Q1 2018 in Review

Virtu Financial sold out of Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) in Q1 2018, closing a stake of 12,391 shares — an estimated $2K sold.

Virtu Financial first reported a position in EYEGW in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 3 funds tracked by Wall St. Rank hold EYEGW as of Q1 2018.

  • Virtu Financial reported no remaining Eyegate Pharmaceuticals, Inc. Warrants position as of Q1 2018 after selling out during the quarter.
  • Virtu Financial sold 12,391 Eyegate Pharmaceuticals, Inc. Warrants shares in Q1 2018, an estimated $2K.
  • Virtu Financial first reported a position in Eyegate Pharmaceuticals, Inc. Warrants in Q3 2017 and held it in 2 quarters.
  • Virtu Financial's Eyegate Pharmaceuticals, Inc. Warrants position peaked at $2K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Eyegate Pharmaceuticals, Inc. Warrants as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.